Skip to main content

Please wait ...

Kathleen Beusterien, MPH

Principal, RWE

Cerner Enviza


Kathleen is Principal, RWE at Cerner Enviza, an Oracle Company. She has over 25 years of experience performing health outcomes research. Kathleen has consulted on a number of communications with the FDA and EMA regarding patient reported outcomes (PRO) endpoints in clinical trials and has developed PRO measures and dossiers for regulatory review. She has numerous preference and PRO publications and regularly leads workshops and presentations at scientific and industry conferences on these areas. She is a founding member of the International Academy of Health Preference Research (IAHPR). 

Product Type
Webinar

What is real world evidence in health and why is it so important to patients, Healthcare practitioners, Pharmaceutical Companies, and the FDA?


Total Credits: 1 Advance Credits

Average Rating:
Not yet rated
Category:
Analysis & Reporting |  Research Design
Speaker(s):
Kathleen Beusterien, MPH |  Rebecca Nash |  Colleen Welsh-Allen
Duration:
1 Hour
Search Description:
Qualitative research is critical in understanding the impact of disease and supporting new health interventions. Cerner Enviza, an Oracle company, will share the background on real world evidence, the growing importance of qualitative inquiry, and the unique role of coding in generating the evidence that matters and to bring the patient voice to advance health care. 
Short Description:
Qualitative research is critical in understanding the impact of disease and supporting new health interventions. Cerner Enviza, an Oracle company, will share the background on real world evidence, the...
Price:
$0.00 - Non-Member Price
Date:

Thu, Dec 01, 2022 - 12:00pm to 01:00pm EST


Showing 1 to 1 of 1 entries